Skip to main content


Educational Information

  • Appropriate Use of Drug Testing in Clinical Addiction Medicine
    The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine is to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction. This document draws on existing empirical evidence and clinical judgment on drug testing with the goal of improving the quality of care that people with addiction receive.
    American Society of Addiction Medicine, 2017
  • Appropriate Use of Drug Testing in Clinical Addiction Medicine
    This document focuses on when, where and how often it is appropriate to perform drug testing in the identification, treatment and recovery of patients with, or at risk for, addiction. These recommendations are not meant to be clinical practice guidelines. ASAM’s intent with this document, is to focus primarily on patients in addiction treatment and recovery, where drug testing is used to assess the patient for a substance use disorder (SUD), monitor the effectiveness of their treatment plan and support recovery, and to also focus on selected special populations at risk for addiction in general healthcare settings.
    Journal of Addiction Medicine, Volume 11, Number 3, May/June 2017
  • Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens
    This report reviews technical information related to detection methods of urine drug tests that are commonly used and provide an overview of false-positive/false-negative data for commonly misused substances in the following categories: cannabinoids, central nervous system (CNS) depressants, CNS stimulants, hallucinogens, designer drugs, and herbal drugs of abuse. It also presents brief discussions of alcohol and tricyclic antidepressants as related to urine drug tests, for completeness. The goal of this review was to provide a useful tool for clinicians when interpreting urine drug test results and making appropriate clinical decisions on the basis of the information presented.
    2016 Mayo Foundation for Medical Education and Research, Mayo Clinic Proceedings. May 2017, 92(5):774-796
  • What’s MAT Got to Do with It? Medication-Assisted Treatment for Opioid Use Disorder in Rural America
    Provides an overview of medication-assisted treatment (MAT), an evidence-based treatment for opioid use disorder, with information on the science behind the disorder and how three MAT medications work. Highlights rural health organizations providing MAT treatment.
    The Rural Monitor, Rural Health Information Hub, March 2018
  • Opioid Addiction: A Chronic Disease
    A brochure describing what drug abuse and opioids are, along with treatment and prescription drug take back program information.
    National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services, January 2018
  • Opioid Use and Treatment Availability
    Fact sheet about opioid use and treatment in rural communities.
    Rural Health Research Gateway, January 2018

Provider Tools

  • Opioid Risk Tool
    Clinical or patient self-report, takes about 1 minute.
    Washington State Agency Medical Directors’ Group, 2015
  • Opioid Risk Tool
    A brief, self-report screening tool designed for use with adult patients in primary care settings to assess risk for opioid abuse among individuals prescribed opioids for treatment of chronic pain.
    Webster, 2005
  • PTSD Screener for Primary Care
    The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screen that was designed for use in primary care settings.
    U.S. Department of Veterans Affairs, National Center for PTSD